These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1728989)

  • 1. Interleukin-6 and its relation to inflammation and disease.
    Hirano T
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S60-5. PubMed ID: 1728989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias.
    Hirano T
    Int J Cell Cloning; 1991 May; 9(3):166-84. PubMed ID: 2061619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 6 and its receptor in the immune response and hematopoiesis.
    Hirano T; Taga T; Matsuda T; Hibi M; Suematsu S; Tang B; Murakami M; Kishimoto T
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():155-66; discussion 166-7. PubMed ID: 2324554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of interleukin 6 in plasmacytomagenesis.
    Hirano T; Suematsu S; Matsusaka T; Matsuda T; Kishimoto T
    Ciba Found Symp; 1992; 167():188-96; discussion 196-200. PubMed ID: 1425013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 in autoimmune disease and chronic inflammatory proliferative disease.
    Ishihara K; Hirano T
    Cytokine Growth Factor Rev; 2002; 13(4-5):357-68. PubMed ID: 12220549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical aspects of interleukin 6.
    Hirano T; Akira S; Taga T; Kishimoto T
    Immunol Today; 1990 Dec; 11(12):443-9. PubMed ID: 2127356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 and plasma cell neoplasias.
    Hirano T; Kishimoto T
    Prog Growth Factor Res; 1989; 1(3):133-42. PubMed ID: 2491260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
    Akira S; Kishimoto T
    Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG1 plasmacytosis in interleukin 6 transgenic mice.
    Suematsu S; Matsuda T; Aozasa K; Akira S; Nakano N; Ohno S; Miyazaki J; Yamamura K; Hirano T; Kishimoto T
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7547-51. PubMed ID: 2798426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 6 and autoimmunity and plasma cell neoplasias.
    Hirano T
    Res Immunol; 1992 Sep; 143(7):759-63. PubMed ID: 1439152
    [No Abstract]   [Full Text] [Related]  

  • 11. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).
    Akira S; Hirano T; Taga T; Kishimoto T
    FASEB J; 1990 Aug; 4(11):2860-7. PubMed ID: 2199284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 in autoimmune disorders.
    Yoshizaki K; Kuritani T; Kishimoto T
    Semin Immunol; 1992 Jun; 4(3):155-66. PubMed ID: 1627787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokines and diseases. Abnormal expression of interleukin 6 and diseases].
    Hirano T
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1401-8. PubMed ID: 1761919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diseases associated with cytokine dysregulation].
    Kishimoto T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):724-34. PubMed ID: 8371004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 overexpression cannot generate serious disorders in severe combined immunodeficiency mice.
    Katsume A; Miyai T; Suzuki H; Moriguchi Y; Kawata H; Tatsumi T; Suematsu S; Kishimoto T; Ohsugi Y
    Clin Immunol Immunopathol; 1997 Feb; 82(2):117-24. PubMed ID: 9000479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans-retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic mice.
    Shima Y; Iwano M; Yoshizaki K; Tanaka T; Kawase I; Nishimoto N
    Nephron Exp Nephrol; 2005; 100(1):e54-62. PubMed ID: 15795517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6 (IL-6) and its receptor (IL-6R) in myeloma/plasmacytoma.
    Suematsu S; Hibi M; Sugita T; Saito M; Murakami M; Matsusaka T; Matsuda T; Hirano T; Taga T; Kishimoto T
    Curr Top Microbiol Immunol; 1990; 166():13-22. PubMed ID: 2073791
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticytokine therapy in autoimmune diseases.
    Nishimoto N; Kishimoto T; Yoshizaki K
    Intern Med; 1999 Feb; 38(2):178-82. PubMed ID: 10225680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multifunctional cytokine (IL-6/BSF-2) and its receptor.
    Hirano T; Taga T; Yamasaki K; Matsuda T; Tang B; Muraguchi A; Horii Y; Suematsu S; Hirata Y; Yawata H
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):29-33. PubMed ID: 2651317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.
    Schirmacher P; Peters M; Ciliberto G; Blessing M; Lotz J; Meyer zum Büschenfelde KH; Rose-John S
    Am J Pathol; 1998 Aug; 153(2):639-48. PubMed ID: 9708822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.